NCT05070663Completed
A Study in Male and Female Adolescent Participants With Severe Uncontrolled Asthma Starting Treatment With Dupilumab Injection (Dupixent®)
National, Multicentre, Non-interventional, Prospective and Retrospective Study in Adolescent Patients With Severe Uncontrolled Asthma Starting Treatment With Dupilumab (Dupixent®)
Source: ClinicalTrials.gov · Last updated 5 Jun 2026
Brief summary (registry, in English)
Primary objective: \- Describe the characteristics of enrolled severe asthma patients Secondary objectives: * Assess the control of asthma under dupilumab (Dupixent®) treatment until 1 year * Assess the clinical objectives of the asthma care * Assess comorbidities associated with Type 2 inflammation * Assess safety during the year of treatment
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 105 (actual)
- First submitted
- 27 Sept 2021
- Start date
- 4 Nov 2021
- Primary completion date
- 14 Mar 2024
- Lead sponsor
- Sanofi
- Diseases
- Asthma
- NCT number
- NCT05070663
What you commit to
- Study type: Observational
- Participants enrolled: 105
- From 4 Nov 2021 to the primary completion date, 14 Mar 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- \- Adult participants ≥ 18 years of age
Other
- The above information is not intended to contain all considerations relevant to a potential participation in a clinical trial.
Who the study is looking for
- Adolescents, for whom initiation of dupilumab (Dupixent®) for the severe uncontrolled asthma indication was decided by the investigator before the inclusion in the study
- Adolescents ≥ 12 and \< 18 years of age at the time of the initiation of Dupixent® treatment
Age in the registry: 12 years to 17 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Investigational site France Coordinator of this site? Confirm its status | France | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.